Clinical Trial Update: Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer [Phase 2]

View source ↗

Summary

This update covers a Phase 2 trial of irinotecan in patients with advanced gallbladder cancer or biliary tract cancer. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• Irinotecan (Irinotecan)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Gallbladder Cancer | Phase 2 | Status: COMPLETED